Peter Böhlen

34.2k total citations · 11 hit papers
223 papers, 27.7k citations indexed

About

Peter Böhlen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter Böhlen has authored 223 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Molecular Biology, 43 papers in Cellular and Molecular Neuroscience and 32 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter Böhlen's work include Angiogenesis and VEGF in Cancer (45 papers), Fibroblast Growth Factor Research (33 papers) and Growth Hormone and Insulin-like Growth Factors (31 papers). Peter Böhlen is often cited by papers focused on Angiogenesis and VEGF in Cancer (45 papers), Fibroblast Growth Factor Research (33 papers) and Growth Hormone and Insulin-like Growth Factors (31 papers). Peter Böhlen collaborates with scholars based in United States, France and Switzerland. Peter Böhlen's co-authors include Sidney Udenfriend, Stanley J. Stein, Wallace Dairman, Frederick Esch, Roger Guillemin, Nicholas Ling, Andrew Baird, Daniel J. Hicklin, Paul Brazeau and Denis Gospodarowicz and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Peter Böhlen

221 papers receiving 25.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range

1972 2.4k citations Peter Böhlen et al. profile →
Fluorometric assay of proteins in the nanogram range

1973 1.5k citations Peter Böhlen et al. profile →
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

1992 1.3k citations Bruce I. Terman, Peter Böhlen et al. Biochemical and Biophysical Research Communications profile →
Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly

1982 1.0k citations Roger Guillemin, Peter Böhlen et al. profile →
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2000 956 citations Daniel J. Hicklin, Peter Böhlen et al. profile →
Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

1985 609 citations Frederick Esch, Andrew Baird et al. profile →
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

1987 585 citations Peter Böhlen et al. profile →
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis

2003 582 citations Larry Witte, Daniel J. Hicklin et al. profile →
Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

1999 557 citations Marie Prewett, Yiwen Li et al. PubMed profile →
A male accessory gland peptide that regulates reproductive behavior of female D. melanogaster

1988 546 citations Peter Böhlen et al. profile →
γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE¹

1977 417 citations Peter Böhlen et al. profile →

Peers

Countries citing papers authored by Peter Böhlen

Since Specialization

Citations

This map shows the geographic impact of Peter Böhlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Böhlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Böhlen more than expected).

Fields of papers citing papers by Peter Böhlen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Böhlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Böhlen. The network helps show where Peter Böhlen may publish in the future.

Co-authorship network of co-authors of Peter Böhlen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Böhlen. A scholar is included among the top collaborators of Peter Böhlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Böhlen. Peter Böhlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models 2004 ·Cancer Research ·Marie Prewett, James R. Tonra, Rajiv Bassi, Andrea T. Hooper, (unknown), Bridget Finnerty, Larry Witte, Peter Böhlen, Zhenping Zhu, Daniel J. Hicklin	13
2	Identification and characterization of a fully human antibody directed against epidermal growth factor receptor for cancer therapy 2004 ·Cancer Research ·Meilin Liu, Haifan Zhang, Xenia Jimenez, Dale L. Ludwig, Larry Witte, Peter Böhlen, Dan Hicklin, Zhenping Zhu	14
3	Dynamic Contrast-Enhanced Magnetic Resonance Imaging Rapidly Indicates Vessel Regression in Human Squamous Cell Carcinomas Grown in Nude Mice Caused by VEGF Receptor 2 Blockade with DC101 2004 ·Neoplasia ·Fabian Kießling, Nabeel Farhan, Matthias P. Lichy, Silvia Vosseler, Melanie Heilmann, Martin Krix, Peter Böhlen, D.W. Miller, Margareta M. Mueller, Wolfhard Semmler, Norbert E. Fusenig, Stefan Delorme	53
4	Simultaneous Blockade of Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor Signaling Pathways in Cancer Cells with a Fully Human Recombinant Bispecific Antibody 2004 ·Journal of Biological Chemistry ·Dan Lu, Haifan Zhang, Dale L. Ludwig, (unknown), Xenia Jimenez, Douglas Burtrum, Paul Balderes, Meilin Liu, Peter Böhlen, Larry Witte, Zhenping Zhu	98
5	Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis 2003 ·The Journal of Immunology ·Michel De Bandt, (unknown), Véronique Ollivier, M Grossin, (unknown), Muriel Gaudry, Peter Böhlen, Kenneth E. Lipson, Audie Rice, Yan Wu, Marie‐Anne Gougerot‐Pocidalo, Catherine Pasquier	103
6	Monoclonal antibody therapeutics and apoptosis 2003 ·Oncogene ·Dale L. Ludwig, Daniel S. Pereira, Zhenping Zhu, Daniel J. Hicklin, Peter Böhlen	59
7	Administration of Antivascular Endothelial Growth Factor Receptor 2 Antibody in the Early Follicular Phase Delays Follicular Selection and Development in the Rhesus Monkey 2002 ·Endocrinology ·Ralf Zimmermann, Ennian Xiao, Peter Böhlen, Michel Ferin	57
8	Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. 2002 ·PubMed ·Fang Liao, Jacqueline Doody, Jay Overholser, Bridget Finnerty, Rajiv Bassi, Yan Wu, Elisabetta Dejana, Paul Kussie, Peter Böhlen, Daniel J. Hicklin	86
9	Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments 2002 ·Journal of Immunological Methods ·Dan Lu, Xenia Jimenez, Haifan Zhang, Peter Böhlen, Larry Witte, Zhenping Zhu	27
10	Development of a High Throughput Screening Assay for Inhibitors of Fibroblast Growth Factor-Receptor-Heparin Interactions 2001 ·SLAS DISCOVERY ·David Aviezer, Andrew P. Seddon, Mary Jo Wildey, Peter Böhlen, Avner Yayon	4
11	Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. 2000 ·PubMed ·Francesca‐Fang Liao, Yiwen Li, William O’Connor, Lucia Zanetta, Rosaria Bassi, Ángel Santiago, James C. Overholser, Andrea T. Hooper, Paolo Mignatti, Elisabetta Dejana, Daniel J. Hicklin, Peter Böhlen	99
12	Biological Activity and Phosphorylation Sites of the Bacterially Expressed Cytosolic Domain of the KDR VEGF-Receptor 1994 ·Biochemical and Biophysical Research Communications ·(unknown), J D Hulmes, Peter Böhlen, Bruce I. Terman	97
13	A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways. 1993 ·Molecular Biology of the Cell ·Véronique Fafeur, Brendan P. O’Hara, Peter Böhlen	27
14	Structure of the Gene Coding for the Human Retinoic Acid-Inducible Factor, MK 1993 ·DNA and Cell Biology ·Jeanette Fairhurst, Peter J. Kretschmer, (unknown), Peter Böhlen, Imre Kovesdi	7
15	Expression of the HBNF (heparin-binding neurite-promoting factor) gene in the brain of fetal, neonatal and adult rat: an in situ hybridization study 1992 ·Developmental Brain Research ·Bertrand Bloch, Elisabeth Normand, Imre Kovesdi, Peter Böhlen	49
16	Fibroblast Growth Factors 1991 ·PubMed ·Andrew Baird, Peter Böhlen	307
17	HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function 1991 ·PubMed ·Peter Böhlen, Imre Kovesdi	61
18	Isolation and characterization of epidermal growth factor from human milk 1985 ·FEBS Letters ·Petro E. Petrides, Markus Hosang, Eric M. Shooter, (unknown), Peter Böhlen	40
19	Isolation and characterization of a γ₁‐melanotropin‐like peptide from bovine neurointermediate pituitary 1981 ·FEBS Letters ·Peter Böhlen, Frederick Esch, Tamotsu Shibasaki, Andrew Baird, Nicholas Ling, Roger Guillemin	37
20	The effect of γ-vinyl GABA and γ-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat 1980 ·Brain Research ·Michael G. Palfreyman, Peter Böhlen, Sylvie Huot, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact